Salem Akel

526 total citations
20 papers, 293 citations indexed

About

Salem Akel is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Salem Akel has authored 20 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Salem Akel's work include Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Mesenchymal stem cell research (4 papers). Salem Akel is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Mesenchymal stem cell research (4 papers). Salem Akel collaborates with scholars based in United States, Jordan and Greece. Salem Akel's co-authors include Francis W. Ruscetti, Stephen H. Bartelmez, Cari Petrow‐Sadowski, Donna Regan, Mary J. Laughlin, Daniel Bertolette, Dimitris Loukopoulos, Kathryn S. Jones, Donna A. Wall and Ying Huang and has published in prestigious journals such as Blood, The Journal of Immunology and Oncogene.

In The Last Decade

Salem Akel

20 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salem Akel United States 9 139 108 102 50 45 20 293
Flávio Henrique Paraguassú-Braga Brazil 6 129 0.9× 48 0.4× 79 0.8× 20 0.4× 28 0.6× 9 292
Armi Salo Finland 7 93 0.7× 129 1.2× 127 1.2× 41 0.8× 54 1.2× 11 327
Thierry Langlois France 7 174 1.3× 157 1.5× 77 0.8× 28 0.6× 19 0.4× 7 317
Kyomi J. Igarashi United States 6 156 1.1× 88 0.8× 48 0.5× 58 1.2× 31 0.7× 8 258
Denise Klatt United States 10 231 1.7× 47 0.4× 98 1.0× 79 1.6× 88 2.0× 19 407
Charlotte Jubert France 11 103 0.7× 95 0.9× 29 0.3× 33 0.7× 52 1.2× 32 347
Chutima Kumkhaek United States 13 160 1.2× 205 1.9× 257 2.5× 48 1.0× 21 0.5× 25 457
Heath L. Bradley United States 12 187 1.3× 116 1.1× 65 0.6× 141 2.8× 163 3.6× 19 427
Yasuhiro Sugio Japan 9 96 0.7× 102 0.9× 29 0.3× 99 2.0× 86 1.9× 32 301
Manan Shah Australia 7 198 1.4× 59 0.5× 152 1.5× 50 1.0× 16 0.4× 17 305

Countries citing papers authored by Salem Akel

Since Specialization
Citations

This map shows the geographic impact of Salem Akel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salem Akel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salem Akel more than expected).

Fields of papers citing papers by Salem Akel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salem Akel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salem Akel. The network helps show where Salem Akel may publish in the future.

Co-authorship network of co-authors of Salem Akel

This figure shows the co-authorship network connecting the top 25 collaborators of Salem Akel. A scholar is included among the top collaborators of Salem Akel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salem Akel. Salem Akel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leonard, Alexis, Akshay Sharma, Yogindra Persaud, et al.. (2024). Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease. Blood. 144(Supplement 1). 2100.1–2100.1. 2 indexed citations
2.
Akel, Salem, Jeoung-Eun Park, Fei Zheng, et al.. (2023). Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axis. Cytotherapy. 25(11). 1149–1154. 2 indexed citations
3.
Sharma, Akshay, Alexis Leonard, Kamille A. West, et al.. (2022). Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor‐mobilized patients with sickle cell disease. British Journal of Haematology. 198(4). 740–744. 13 indexed citations
4.
Riberdy, Janice M., Fei Zheng, Jeoung-Eun Park, et al.. (2022). Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells. Gene Therapy. 30(3-4). 222–231. 8 indexed citations
5.
Flanagan, Michael, et al.. (2021). Umbilical mesenchymal stem cell-derived extracellular vesicles as enzyme delivery vehicle to treat Morquio A fibroblasts. Stem Cell Research & Therapy. 12(1). 276–276. 13 indexed citations
6.
Talleur, Aimee C., Salem Akel, Akshay Sharma, et al.. (2020). Haploidentical CD45RA-Negative Donor Lymphocyte Infusions Are Feasible, Safe and Associated with Clinical Benefit. Biology of Blood and Marrow Transplantation. 26(3). S268–S268. 3 indexed citations
8.
Emnett, Ryan J., et al.. (2016). Evaluation of Tissue Homogenization to Support the Generation of GMP‐Compliant Mesenchymal Stromal Cells from the Umbilical Cord. Stem Cells International. 2016(1). 3274054–3274054. 7 indexed citations
11.
Akel, Salem, et al.. (2013). Sterility testing of minimally manipulated cord blood products: validation of growth‐based automated culture systems. Transfusion. 53(12). 3251–3261. 11 indexed citations
12.
Akel, Salem, Daniel Bertolette, Cari Petrow‐Sadowski, & Francis W. Ruscetti. (2007). Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells. Platelets. 18(8). 566–578. 9 indexed citations
13.
Ruscetti, Francis W., Salem Akel, & Stephen H. Bartelmez. (2005). Autocrine transforming growth factor-β regulation of hematopoiesis: many outcomes that depend on the context. Oncogene. 24(37). 5751–5763. 90 indexed citations
14.
Jones, Kathryn S., Salem Akel, Cari Petrow‐Sadowski, et al.. (2005). Induction of Human T Cell Leukemia Virus Type I Receptors on Quiescent Naive T Lymphocytes by TGF-β,. The Journal of Immunology. 174(7). 4262–4270. 29 indexed citations
15.
Akel, Salem, et al.. (2005). Amifostine exerts anti-angiogenic activity and suppresses vascular endothelial growth factor secreted by hemopoietic stem/progenitor cells.. PubMed. 26(10). 1523–8. 2 indexed citations
17.
Viniou, Nora, Evangelos Terpos, Salem Akel, et al.. (2002). Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response. Annals of Hematology. 81(4). 182–186. 5 indexed citations
18.
Akel, Salem, A Kolialexi, Ariadni Mavrou, et al.. (2002). Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings. Clinical & Laboratory Haematology. 24(6). 361–367. 7 indexed citations
19.
Penzo, Marianna, et al.. (2001). Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures.. PubMed. 86(7). 700–5. 24 indexed citations
20.
Akel, Salem, Aggeliki Kοlialexi, Ariadni Mavrou, et al.. (2000). Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients. Cancer Genetics and Cytogenetics. 122(2). 93–100. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026